Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The rise in the global prevalence of diabetes, particularly among younger people, has led to an increase in the number of pregnant women with preexisting diabetes, many of whom have diabetes-related microvascular complications. We aimed to estimate the magnitude of the risks of adverse pregnancy outcomes or disease progression in this population. METHODS AND FINDINGS: We undertook a systematic review and meta-analysis on maternal and perinatal complications in women with type 1 or 2 diabetic microvascular disease and the risk factors for worsening of microvascular disease in pregnancy using a prospective protocol (PROSPERO CRD42017076647). We searched major databases (January 1990 to July 2021) for relevant cohort studies. Study quality was assessed using the Newcastle-Ottawa Scale. We summarized the findings as odds ratios (ORs) with 95% confidence intervals (CIs) using random effects meta-analysis. We included 56 cohort studies involving 12,819 pregnant women with diabetes; including 40 from Europe and 9 from North America. Pregnant women with diabetic nephropathy were at greater risk of preeclampsia (OR 10.76, CI 6.43 to 17.99, p < 0.001), early (<34 weeks) (OR 6.90, 95% CI 3.38 to 14.06, p < 0.001) and any preterm birth (OR 4.48, CI 3.40 to 5.92, p < 0.001), and cesarean section (OR 3.04, CI 1.24 to 7.47, p = 0.015); their babies were at higher risk of perinatal death (OR 2.26, CI 1.07 to 4.75, p = 0.032), congenital abnormality (OR 2.71, CI 1.58 to 4.66, p < 0.001), small for gestational age (OR 16.89, CI 7.07 to 40.37, p < 0.001), and admission to neonatal unit (OR 2.59, CI 1.72 to 3.90, p < 0.001) compared to those without nephropathy. Diabetic retinopathy was associated with any preterm birth (OR 1.67, CI 1.27 to 2.20, p < 0.001) and preeclampsia (OR 2.20, CI 1.57 to 3.10, p < 0.001) but not other complications. The risks of onset or worsening of retinopathy were increased in women who were nulliparous (OR 1.75, 95% CI 1.28 to 2.40, p < 0.001), smokers (OR 2.31, 95% CI 1.25 to 4.27, p = 0.008), with existing proliferative disease (OR 2.12, 95% CI 1.11 to 4.04, p = 0.022), and longer duration of diabetes (weighted mean difference: 4.51 years, 95% CI 2.26 to 6.76, p < 0.001) compared to those without the risk factors. The main limitations of this analysis are the heterogeneity of definition of retinopathy and nephropathy and the inclusion of women both with type 1 and type 2 diabetes. CONCLUSIONS: In pregnant women with diabetes, presence of nephropathy and/or retinopathy appear to further increase the risks of maternal complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the presence of microvascular complications is associated with higher risk of disease progression and adverse pregnancy outcomes (22).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
(2014) · Medical Entomology and Zoology · Cited by 17,633
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Pregnancy complicating diabetes
White, P. (1949) · The American Journal of Medicine · doi:10.1016/0002-9343(49)90382-4 · Cited by 414 · cited 1×
“Retinopathy was either graded using modifications of White’s classification system for diabetic complications in pregnancy [15] or according to background, preproliferative, and proliferative status.”
MethodMetabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402 · cited 1×
“21, I(2) = 0%; 4 studies) was not found to affect retinopathy progression) [54,62,67,72].”
BackgroundPregnancy complicating diabetes.
White, P. (1946) · PubMed · Cited by 392
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Effect of Pregnancy on Progression of Diabetic Retinopathy
Klein, B. E. K., Moss, S. E., & Klein, R. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.34 · Cited by 354 · cited 1×
“We limited our analysis of disease progression to only pregnancy as observational studies suggest that diabetic retinopathy deteriorates more rapidly in pregnancy [9,67,77], but the findings may not necessarily translate into worse long-term retinopathic severity when compared to women who were not pregnant [81].”
ResultBell, R., Glinianaia, S. V., Tennant, P. W. G., Bilous, R. W., & Rankin, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2455-y · Cited by 224 · cited 1×
“001, I(2) = 0%; 6 studies) [16,18,21,22,30,37], small for gestational age fetus (OR 16.”
Pregnancy outcome in type 1 diabetic women with microalbuminuria
Ekbom, P., Damm, P., Feldt-Rasmussen, B., Feldt-Rasmussen, U., Mølvig, J., & Mathiesen, E. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1739 · Cited by 224 · cited 4×
“03, I(2) = 0%; 6 studies) [18,22,25,27,30,38], and neonatal unit admission (OR 2.”
BackgroundInfluentialPreeclampsia in diabetic pregnancies
Garner, P. R., D'Alton, M. E., Dudley, D. K., Huard, P., & Hardie, M. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)91184-e · Cited by 211
Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic Nephropathy
Ringholm Nielsen, L., Damm, P., & Mathiesen, E. R. (2009) · Diabetes Care · doi:10.2337/dc08-1526 · Cited by 204 · cited 2×
“03, I(2) = 0%; 6 studies) [18,22,25,27,30,38], and neonatal unit admission (OR 2.”
Jardine, J., Relph, S., Magee, L., von Dadelszen, P., Morris, E., Ross‐Davie, M., Draycott, T., & Khalil, A. (2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16547 · Cited by 199 · cited 1×
“During the Coronavirus Disease 2019 (COVIDAU : PleasenotethatCOVID 19hasbeendefinedasCoronavirusDisease2019atitsfirstmentioninthesentenceDuringtheCoronavirusDisease2019ðCOVID 19Þpandemic; pregnant:::Pleasecorrectifnecessary: -19) pandemic, pregnant women with preexisting diabetes are also in the highest risk groups fo…”
BackgroundSelf-citationProgression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy
Rosenn, B., Miodovnik, M., Kranias, G., Khoury, J., Combs, C. A., Mimouni, F., Siddiqi, T. A., & Lipman, M. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90608-5 · Cited by 169 · cited 1×
“21, I(2) = 0%; 4 studies) was not found to affect retinopathy progression) [54,62,67,72].”
BackgroundDoes pregnancy increase the risk for development and progression of diabetic nephropathy?
Miodovnik, M., Rosenn, B., Khoury, J. C., Grigsby, J. L., & Siddiqi, T. A. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70660-9 · Cited by 148
Purdy, L. P., Hantsch, C. E., Molitch, M. E., Metzger, B. E., Phelps, R. L., Dooley, S. L., & Hou, S. H. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1067 · Cited by 138
Diabetic Retinopathy during Pregnancy
Axer‐Siegel, R., Hod, M., Fink‐Cohen, S., Kramer, M., Weinberger, D., Schindel, B., & Yassur, Y. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30421-1 · Cited by 136
Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes
Temple, R. C., Aldridge, V. A., Sampson, M. J., Greenwood, R. H., Heyburn, P. J., & Glenn, A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00535.x · Cited by 131
Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes
Rasmussen, K. L., Laugesen, C. S., Ringholm, L., Vestgaard, M. J., Damm, P., & Mathiesen, E. R. (2010) · Diabetologia · doi:10.1007/s00125-010-1697-9 · Cited by 129 · cited 1×
“2%, 4 studies) [56,60,63,66] between women with and without new or progressive retinopathy.”
BackgroundPerinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy
Gordon, M. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00420-3 · Cited by 125
Diabetic Nephropathy in Pregnancy: Suboptimal Hypertensive Control Associated With Preterm Delivery
CARR, D., KOONTZ, G., GARDELLA, C., HOLING, E., BRATENG, D., BROWN, Z., & EASTERLING, T. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.12.010 · Cited by 125 · cited 1×
“There were 6 studies identified, which assessed how glycemia control affected progression of retinopathy [62,72,77–80], one of which also assessed progression of nephropathy [79].”
BackgroundChodankar, R., Howie, R., Lim, C. C., & Mahmood, T. A. (2021) · The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology · doi:10.1017/9781108863049.068 · Cited by 116
Hiilesmaa, V., Suhonen, L., & Teramo, K. A. (2000) · Diabetologia · doi:10.1007/s001250051565 · Cited by 115 · cited 1×
“05, I(2) = 0%; 5 studies) [25,31,32,39,40], although the latter was of borderline statistical significance.”
BackgroundDiabetic retinopathy in pregnancy: a review
Morrison, J. L., Hodgson, L. A., Lim, L. L., & Al‐Qureshi, S. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12760 · Cited by 115 · cited 1×
“Diabetic retinopathy, the leading cause of blindness in reproductive aged women [6], affects 1 in 7 pregnant women with type 2 diabetes and almost half of pregnant women with type 1 diabetes [7].”
BackgroundPregnancies in women with diabetic nephropathy: long-term outcome for mother and child
Kimmerle, R., Za�, R.-P., Cupisti, S., SOMVILLE, T., Bender, R., Pawlowski, B., & Berger, M. (1995) · Diabetologia · doi:10.1007/bf00400099 · Cited by 107 · cited 3×
“001, I(2) = 0%; 6 studies) [16,18,21,22,30,37], small for gestational age fetus (OR 16.”
BackgroundAssociations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy
Howarth, C., Gazis, A., & James, D. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02254.x · Cited by 92 · cited 2×
“01, I(2) = 0%; 7 studies) [25,26,43,47,49,50,52], and cesarean birth (OR 5.”
BackgroundADIPS 2020 guideline for pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., Hughes, R. C. E., Barrett, H. L., Lagstrom, J., Porter, C., Britten, F. L., Glastras, S. J., Fulcher, I., Wein, P., et al. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13265 · Cited by 87 · cited 2×
“The Australian Diabetes in Pregnancy Society guidelines also comment on the same outcomes from a narrative review with 3 small studies [74].”
BackgroundTHE NATIONAL PERINATAL EPIDEMIOLOGY UNIT
(1983) · The Lancet · doi:10.1016/s0140-6736(83)92366-8 · Cited by 84
Diabetic Retinopathy in Pregnancy: A Population-Based Study of Women with Pregestational Diabetes
Egan, A. M., McVicker, L., Heerey, A., Carmody, L., Harney, F., & Dunne, F. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/310239 · Cited by 80 · cited 1×
“2%, 4 studies) [56,60,63,66] between women with and without new or progressive retinopathy.”
BackgroundEarly‐pregnancy proteinuria in diabetes related to preeclampsia
Combs, C. A., Rosenn, B., Kitzmiller, J. L., Khoury, J. C., Wheeler, B. C., & Miodovnik, M. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90322-0 · Cited by 80
Hanson, U., & Persson, B. (1998) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1998.770608.x · Cited by 79 · cited 1×
“05, I(2) = 0%; 5 studies) [25,31,32,39,40], although the latter was of borderline statistical significance.”
BackgroundVascular Complications in the Diabetic Pregnancy
Leguizamón, G. F., Trigubo, D., Pereira, J. I., Vera, M. F., & Fernández, J. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0586-5 · Cited by 79 · cited 2×
“Diabetic nephropathy is reported in 5% to 10% of pregnant women with type 1 diabetes [4] and about 2% to 3% with type 2 diabetes [5].”
BackgroundRetinal blood flow changes during pregnancy in women with diabetes.
Chen, H. C., Newsom, R., Patel, V. B., CASSAR, J., Mather, H. M., & KOHNER, E. M. (1994) · PubMed · Cited by 76
Diabetic Nephropathy and Microalbuminuria in Pregnant Women With Type 1 and Type 2 Diabetes
Damm, J. A., Ásbjörnsdóttir, B., Callesen, N., Mathiesen, J. M., Ringholm, L., Pedersen, B. W., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc13-1031 · Cited by 74
Pregnancy Performance and Outcomes Associated with Diabetic Nephropathy
Reece, E. A., Leguizamón, G. F., & Homko, C. J. (1998) · American Journal of Perinatology · doi:10.1055/s-2007-993968 · Cited by 72 · cited 1×
“The few available systematic reviews are narrative and mainly provided noncomparative estimates of maternal–fetal pregnancy outcomes in women with preexisting diabetic nephropathy [73].”
BackgroundPregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy
Dunne, F. P. (1999) · QJM · doi:10.1093/qjmed/92.8.451 · Cited by 69
Progression of retinopathy during pregnancy in type 1 diabetes mellitus
Rahman, W., Rahman, F. Z., Yassin, S., Al‐Suleiman, S. A., & Rahman, J. (2007) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01413.x · Cited by 65
Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes
Temple, R., Aldridge, V, Stanley, K., & Murphy, H. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01071.x · Cited by 63
Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes
Arun, C. S., & Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-0994-z · Cited by 57
Increased Serum IGF-I During Pregnancy Is Associated With Progression of Diabetic Retinopathy
Lauszus, F. F., Klebe, J. G., Bek, T., & Flyvbjerg, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.852 · Cited by 55
Haeri, S., Khoury, J. C., Kovilam, O. P., & Miodovnik, M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.066 · Cited by 54 · cited 3×
“01, I(2) = 60%; 6 studies) [21,43,44,47,50,53] compared to those without any microvascular complication (Table 1).”
BackgroundYoung, E. C., Pires, M. L. E., Marques, L. P. J., de Oliveira, J. E. P., & Zajdenverg, L. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.013 · Cited by 50
Melamed, N., Chen, R., Soiberman, U., Ben‐Haroush, A., Hod, M., & Yogev, Y. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0541-z · Cited by 48
Nørgaard, S. K., Vestgaard, M. J., Jørgensen, I. L., Ásbjörnsdóttir, B., Ringholm, L., McIntyre, D. H., Damm, P., & Mathiesen, E. R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.014 · Cited by 47 · cited 1×
“05, I(2) = 0%; 5 studies) [25,31,32,39,40], although the latter was of borderline statistical significance.”
BackgroundBourry, J., Courteville, H., Ramdane, N., Drumez, É., Duhamel, A., Subtil, D., Deruelle, P., & Vambergue, A. (2020) · Diabetes Care · doi:10.2337/dc20-0904 · Cited by 41 · cited 1×
“2%, 4 studies) [56,60,63,66] between women with and without new or progressive retinopathy.”
BackgroundStatistical Analysis of Perinatal Outcomes in Pregnancy Complicated with Diabetes Mellitus
Zhu, L., Nakabayashi, M., & Takeda, Y. (1997) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.1997.tb00886.x · Cited by 40 · cited 2×
“01, I(2) = 60%; 6 studies) [21,43,44,47,50,53] compared to those without any microvascular complication (Table 1).”
BackgroundRetinal Artery and Vein Diameters during Pregnancy in Diabetic Women
Larsen, M., Colmorn, L. B., Boennelycke, M., Kaaja, R., Immonen, I., Sander, B., & Loukovaara, S. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0604 · Cited by 40
Determinants of preeclampsia in women with type 1 diabetes
Gutaj, P., Zawiejska, A., Mantaj, U., & Wender-Ożegowska, E. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1053-3 · Cited by 39
Biesenbach, G., Grafinger, P., Zazgornik, J., & Stöger, H. (2000) · Renal Failure · doi:10.1081/jdi-100100898 · Cited by 37 · cited 5×
“001, I(2) = 0%; 6 studies) [16,18,21,22,30,37], small for gestational age fetus (OR 16.”
BackgroundInfluentialRingholm, L., Vestgaard, M. J., Laugesen, C. S., Juul, A., Damm, P., & Mathiesen, E. R. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.12.001 · Cited by 37 · cited 1×
“38, I(2) = 0%, 2 studies) [55,71] or when including women with type 1 diabetes only (OR 2.”
BackgroundKlemetti, M. M., Laivuori, H. M., Tikkanen, M., Nuutila, M. E., Hiilesmaa, V. K., & Teramo, K. A. (2015) · Diabetologia · doi:10.1007/s00125-015-3787-1 · Cited by 37 · cited 6×
“01, I(2) = 0%; 7 studies) [25,26,43,47,49,50,52], and cesarean birth (OR 5.”
BackgroundInfluentialThe effect of pregnancy on the progression of diabetic retinopathy
Toda, J., Kato, S., Sanaka, M., & Kitano, S. (2016) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-016-0464-y · Cited by 34 · cited 1×
“2%, 4 studies) [56,60,63,66] between women with and without new or progressive retinopathy.”
Background(1999) · PubMed · Cited by 33
Neonatal Morbidity in Infants of Diabetic Mothers
Gamsu, H. R. (1978) · Journal of the Royal Society of Medicine · doi:10.1177/014107687807100313 · Cited by 30 · cited 1×
“01, I(2) = 0%; 7 studies) [25,26,43,47,49,50,52], and cesarean birth (OR 5.”
Lauszus, F. F., Rasmussen, O., Lousen, T., Klebe, T., & Klebe, J. G. (2001) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2001.801204.x · Cited by 30 · cited 1×
“05, I(2) = 0%; 5 studies) [25,31,32,39,40], although the latter was of borderline statistical significance.”
BackgroundCastiglioni, M. T., Valsecchi, L., Cavoretto, P. I., Pirola, S., Piazza, L. D., Maggio, L., Caretto, A., Garito, T., Rosa, S., & Scavini, M. (2013) · Pregnancy Hypertension · doi:10.1016/j.preghy.2013.09.001 · Cited by 27
Fetal Weight and Progression of Diabetic Retinopathy
McElvy, S. S., Demarini, S., Miodovnik, M., Khoury, J. C., Rosenn, B., & Tsang, R. C. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01202-3 · Cited by 22 · cited 1×
“38, I(2) = 0%, 2 studies) [55,71] or when including women with type 1 diabetes only (OR 2.”
BackgroundFactors Associated With Cesarean Delivery in Nulliparous Women With Type 1 Diabetes
Lepercq, J. A., Meaux, J. P. L., Agman, A., & Timsit, J. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181d992ab · Cited by 22 · cited 2×
“34, I(2) = 86%; 2 studies) [36,44] or pregnancy-induced hypertension (OR 1.”
BackgroundSevere Diabetic Nephropathy in Type 1 Diabetes and Pregnancy - A Case Series
Piccoli, G. B., Tavassoli, E., Melluzza, C., Grassi, G., Monzeglio, C., Donvito, V., Leone, F., Attini, R., Ghiotto, S., Clari, R., et al. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.68 · Cited by 19
Yogev, Y., Chen, R., Ben‐Haroush, A., Hod, M., & Bar, J. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903544744 · Cited by 19
Diabetische Retinopathie und Nephropathie - Komplikationen während Schwangerschaft und Geburt
Hopp, H., Vollert, W., Ebert, A. D., Weitzel, H. K., Glöckner, E., & Jährig, D. (1995) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2007-1023317 · Cited by 19
Pregnancy and neonatal outcomes in women with type 1 diabetes mellitus
Durackova, L., Krištúfková, A., & Korbeľ, M. (2017) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2017_011 · Cited by 19 · cited 2×
“01, I(2) = 60%; 6 studies) [21,43,44,47,50,53] compared to those without any microvascular complication (Table 1).”
BackgroundEffect of pregnancy on diabetic nephropathy and retinopathy.
Irfan, S., Arain, T. M., Shaukat, A., & Shahid, A. (2004) · PubMed · Cited by 17
Stalnikiewicz, L., Floriot, M., Guerci, B., & Angioï-Duprez, K. (2010) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2010.06.005 · Cited by 12
Samii, L., Kallas‐Koeman, M. M., Donovan, L., Lodha, A. K., Crawford, S., & Butalia, S. (2018) · Diabetic Medicine · doi:10.1111/dme.13872 · Cited by 7 · cited 2×
“01, I(2) = 46%; 3 studies) [21,47,49] and 37 weeks’ (OR 2.”
Perinatal Morbidity of Infants of Diabetic Mothers
Hoshi, J., Nishida, H., Takahashi, N., Kabe, K., Watanabe, Y., Arai, T., Yamada, T., Yamaguchi, K., & Sakamoto, S. (1991) · Pediatrics International · doi:10.1111/j.1442-200x.1991.tb01536.x · Cited by 6
Lövestam-Adrian (1997) · Research Portal (Queen's University Belfast) · doi:10.1002/(sici)1096-9136(199712)14:12 · Cited by 4
[Developmental aspects of diabetic retinopathy during pregnancy].
Ayed, S., Jeddi, A., Daghfous, F., el Euch, M., Ben Osman, N., Marrakchi, S., & Nacef, L. (1992) · PubMed · Cited by 4
Diabetic nephropathy in pregnant women with type 1 diabetes mellitus
Themeli, Y., Bajrami, V., Idrizi, A., Zaimi, K., Mustafaraj, K., Shtylla, A., Peci, E., & Gjoshe, J. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 3
Diglas, J., Bali, C., Simon, C., Strassegger-Böhm, D., & Irsigler, K. (1997) · PubMed · Cited by 3
Effect of Pregnancy on Diabetic Retinopathy
Maayah, J. F., Shammas, A. G., & Haddadin, A. (2001) · Cited by 3
Stalnikiewicz, L., & Angioï-Duprez, K. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
PP.27 Micro-Vascular Disease at Booking in T1DM and Associated Risk of Developing Pre-Eclampsia
Patel, N., Brackenridge, A., Kanji, A., Pasupathy, D., & Rajasingam, D. (2013) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2013-303966.307 · Cited by 1
[Neonatal morbidity of children of diabetic mothers].
Schoetzau, A., & Hillebrand, B. (1990) · PubMed · Cited by 1
Pregnancy outcome of mothers with diabetic nephropathy
Ivanišević, M., Bljajić, D., Ljubas, N., & Đelmiš, J. (2007) · Cited by 1
Research works printed but not linked: 4
- Knight M, Bunch K, Tuffnell D, Shakespeare J, Kotnis R, Kenyon S, et al. Saving Lives, Improving Mothers’ Care. 2019.
- National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. 2015. 32212588
- Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F, Damm P, Mathiesen E. Higher levels of Atrial Natriuretic Peptide (ANP) are present in early pregnancy in type 1 diabetic women developing preeclampsia, September 2011, vol/is 54/. 2011: S485.
- Dodesini A, Maffeis A, Corsi A, Benvenuto A, Ciriello E, Lepore G, et al. In type 1 diabetic women retinopathy and nephropathy are predictors of caesarean delivery independently of glucose control. Diabetes. 2009; 58.
Cited by
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Guo, P., Yin, J., Xiang, Z., Chen, D. D., Xu, P., Wang, X., Zhang, W., Mao, M., Zheng, Q., & Feng, S. (2022) · Journal of Medical Internet Research · doi:10.1136/bmjopen-2022-061151 · Cited by 31
Metadata
- Authors
- Relph, S., Patel, T., Delaney, L., Sobhy, S., & Thangaratinam, S.
- Affiliations
- King's College London (GB)
- Royal Free London NHS Foundation Trust (GB)
- Queen Mary University of London (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Corresponding author
- Thangaratinam, Shakila
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-11-22
- Volume
- 18
- Issue
- 11
- Pages
- e1003856
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC8654151
- OpenAlex
- W3216427723
- Cited by
- 54
- References
- 78
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 14 · 2023: 12 · 2022: 8 · 2021: 1
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-12-08)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute for Health and Care Research (NIHR202435, CL-2016-19-002)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- diabetes in pregnancy, diabetic microangiopathy, diabetic nephropathy, preeclampsia, preterm birth, cesarean section, perinatal mortality, congenital malformations, small for gestational age, neonatal admission, disease progression, type 1 diabetes, type 2 diabetes, maternal complications, perinatal complications, risk factors
- MeSH terms
- Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Risk Factors, Publication Bias, Disease Progression, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.